Narrow search
Showing 1 - 10 of 578
Cover Image
On the design of equity-oriented pharmaceutical copayments
González, Paula - In: SERIEs : Journal of the Spanish Economic Association 11 (2020) 2, pp. 179-202
claims to incorporate criteria of distributive justice into the design of copayments. We find that if the government … constrains patient rights to what is medically feasible, equity-based copayments vary from a percentage of the cost of the … patients, then copayments based on equity lead to a relation between copayments and clinical status that diverges from those …
Persistent link: https://www.econbiz.de/10012240615
Cover Image
Ending Covid-19 vaccine apartheid through vaccine donations : the influence of supply chains
Goel, Rajeev K.; Nelson, Michael A. - 2023
We study determinants of COVID-19 vaccine donations from recipients' perspective, especially considering supply chain and institutional weakness (corruption) aspects. Results, based on data from more than 131 nations, show that strengthened supply chains reduced donations. The impacts of...
Persistent link: https://www.econbiz.de/10014393223
Cover Image
Allocating Medicine Fairly in an Unfair Pandemic
Persad, Govind - 2021
America’s COVID-19 pandemic has both devastated and disparately harmed minority communities. How can the allocation of scarce treatments for COVID-19 and similar public health threats fairly and legally respond to these racial disparities? Some have proposed that members of racial groups who...
Persistent link: https://www.econbiz.de/10013237725
Cover Image
Reserve System Design for Allocation of Scarce Medical Resources in a Pandemic : Some Perspectives from the Field
Pathak, Parag A.; Persad, Govind; Sönmez, Tayfun; … - National Bureau of Economic Research - 2022
The Covid-19 pandemic has brought renewed attention to rationing guidelines for scarce medical resources. This paper describes the benefits of using a reserve system over a priority system in operationalizing compromises between certain ethical goals. In the last two years, more than a dozen...
Persistent link: https://www.econbiz.de/10013210092
Cover Image
Stable Allocations of Vaccines in a Political Economy
Nganmeni, Zephirin; Pongou, Roland; Tchantcho, Bertrand; … - 2021
We develop a theory that addresses the problem of the existence of stable vaccine allocations in a political economy. These are allocation policies that a political leader can enforce without losing their popularity. Our analysis distinguishes between contexts where vaccination has positive...
Persistent link: https://www.econbiz.de/10013313961
Cover Image
A mathematical model for equitable in-country COVID-19 vaccine allocation
Balcik, Burcu; Yucesoy, Ecem; Akca, Berna; Karakaya, Sirma - In: International journal of production research 60 (2022) 24, pp. 7502-7526
Persistent link: https://www.econbiz.de/10013502452
Cover Image
Fair and efficient vaccine allocation : a generalized Gini index approach
Gutjahr, Walter J. - In: Production and operations management : the flagship … 32 (2023) 12, pp. 4114-4134
Persistent link: https://www.econbiz.de/10014441497
Cover Image
Choosing among competing blockbusters: Does the identity of the third-party payer matter for prescribing doctors?
Dalen, Dag Morten; Storisio, Enrico; Strøm, Steinar - 2009
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10010275649
Cover Image
A prescription for knowledge: Patient information and generic substitution
Hjalmarsson, Linn; Schmid, Christian; Schreiner, Nicolas - 2024
Markets require informed participants to function efficiently. This paper examines the impact of providing targeted information directly to patients on their purchasing-decisions regarding pharmaceutical drugs. We analyze the effect of informational letters sent by a Swiss health insurer to...
Persistent link: https://www.econbiz.de/10014564096
Cover Image
A pharmaceutical innovation : is it worth the money? Whose money?
Sennhauser, Michèle; Zweifel, Peter - 2009
This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...
Persistent link: https://www.econbiz.de/10003900791